The Thorough QT/QTc Study of TS-071 in Healthy Subjects
Phase 2
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-jRCT2080222303
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Healthy Japanese subjects
etc.
Exclusion Criteria
The subject has hepatic/biliary, respiratory, cardiovascular, gastrointestinal, urological, renal, endocrine or immunological disorder, malignant tumor, diabetes mellitus or impaired glucose tolerance
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QTcF
- Secondary Outcome Measures
Name Time Method QTcB, QT interval corrected by Bazett's formula, etc.